IonQ’s Steep Slide Draws Contrarian Options Bets as Insider Sales Tell a More Nuanced Story
Published on 07/22/2026 at 18:03 | Redaktion boerse-global.de
IonQ has shed nearly 39% of its value over the past month, a brutal stretch that has pushed the quantum computing stock deep into oversold territory. Yet beneath the surface, two seemingly contradictory forces are at play: institutional traders are quietly placing million-dollar bets on a rebound, while company insiders have been selling shares in volumes that would alarm any casual observer. The truth, as is often the case, lies somewhere in between.
The stock closed recently at €31.29, virtually flat on the day but a far cry from the 52-week high of €73.10 reached in October 2025. The Relative Strength Index has sunk to 29.4—a classic oversold reading that often precedes a short-term bounce. With annualized volatility hovering near 67%, the trading action in IonQ has been nothing short of frenetic.
The Insider Selling Picture: Less Alarming Than It Appears
A recent analysis by Motley Fool flagged that insiders across IonQ, Rigetti, and D-Wave have collectively sold roughly $988 million worth of shares since mid-2021. The headline figure is jarring, but the details reveal a more measured reality.
The bulk of recent insider transactions at IonQ have been executed through pre-arranged trading plans under SEC Rule 10b5-1. These are not impulsive decisions made in response to market conditions; they are programs set months in advance. Director Robert T. Cardillo, for instance, sold shares in February, April, and May under a plan established on March 12, 2025, and later amended in June. A portion of those sales—3,071 shares—was simply to cover tax obligations tied to the vesting of restricted stock units.
Should investors sell immediately? Or is it worth buying IonQ?
Director John W. Raymond similarly sold shares in June under a plan dated March 19, 2026, which authorizes the sale of up to 18,253 shares through February 2028. IonQ has confirmed these details in its quarterly filings.
Not all insider activity has been one-directional. A February report noted that two IonQ directors purchased roughly $2.1 million worth of stock, later revised to about $2.25 million. Still, the net selling bias across the sector remains pronounced.
Institutional Call Buying Suggests a Different Outlook
Options trader Andrew Keene has been tracking unusually large call purchases in IonQ for weeks. One trader recently bought November calls with a $60 strike price, representing a $1.5 million bet. Keene himself entered a position, alongside January calls with longer expiration dates.
The activity extends beyond IonQ. Keene’s radar also includes X-Energy and Oklo, both of which have suffered steep declines from their highs. At Oklo, the largest single wager stands at roughly 50,000 December calls, representing a notional value in the tens of millions. Rigetti and D-Wave are also on his watchlist, though Keene notes that IonQ is seeing the largest absolute dollar volume among the quantum names.
Keene is careful to temper expectations. He has traded IonQ profitably before and believes in the long-term thesis for quantum computing, but he acknowledges that none of the three companies are profitable. If sentiment toward revenue-light growth stocks sours or interest rates rise further, all three could fall deeper. Institutional call buying, he warns, is no guarantee of direction.
Valuation and Technicals Paint a Mixed Picture
The valuation multiples in the quantum computing space remain eye-popping. At one point, IonQ traded at 109 times revenue, Rigetti at 836 times, and D-Wave at 791 times. For context, historically transformative technology trends have typically topped out at around 30 times sales.
The technical picture offers a glimmer of hope for short-term traders. With the RSI at 29.1, the stock is flashing oversold signals that have historically preceded countertrend rallies. But the broader trend remains firmly negative: IonQ is down roughly 22% year-to-date, and the gap from its October 2025 peak now exceeds 57%.
IonQ at a turning point? This analysis reveals what investors need to know now.
Earnings on the Horizon
The next quarterly report is shaping up as a pivotal moment. Analysts expect a loss of $0.29 per share, a 58.57% improvement from the year-ago quarter. Revenue is forecast at $66.36 million, representing a 220.73% surge. For the full year, the consensus calls for a loss of $1.07 per share on revenue of $267.45 million—improvements of 41.21% and 105.71%, respectively, versus the prior year.
Zacks ranks IonQ a 3, equivalent to a Hold rating. The broader industry category, “Computer – Integrated Systems,” sits in the top 8% of more than 250 industries tracked by the firm.
The current dynamic is a study in contrasts. On one side, traders are positioning for a recovery from deeply oversold levels. On the other, the stock continues to drift lower in daily trading. The upcoming earnings report will test whether IonQ’s accelerating revenue growth can outweigh the persistent valuation concerns that have weighed on the quantum computing sector.
Ad
IonQ Stock: New Analysis - 22 July
Fresh IonQ information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
